Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centers for Disease Control and Prevention | FED |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertussis (Tdap), human papillomavirus (HPV), and meningococcal conjugate vaccine (MCV4) and all three combined) among eligible students enrolled in schools with a comprehensive school-based immunization program will be significantly higher than that of students enrolled in schools without a school-based immunization program.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| School Located Vaccine (SLV) Program | Experimental | A vaccine program carried out by a community vaccinator will be conducted in a limited number of participating schools. The program will be open to the students enrolled at the participating schools |
|
| no School Located Vaccine (SLV) Program | No Intervention | Schools that are part of the non-intervention arm of the study will not have a school-located vaccine program. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| School Located Vaccine (SLV) Program | Behavioral | A community vaccinator will administer vaccines to students whose parents consent for their child to participate |
|
| Measure | Description | Time Frame |
|---|---|---|
| The likelihood of vaccination among eligible 6th grade students with one or more needed vaccines in intervention schools compared to control schools. | The vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. | end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| The likelihood of vaccination among eligible 6th grade students with Tdap vaccine in intervention schools compared to control schools. | The Tdap vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. | end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| The likelihood of vaccination among eligible 6th grade students with MCV4 vaccine in intervention schools compared to control schools. | The MCV4 vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. | end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| The likelihood of vaccination among eligible 6th grade female students with HPV vaccine in intervention schools compared to control schools. | The HPV vaccination status of eligible female students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. |
| Measure | Description | Time Frame |
|---|---|---|
| The likelihood of vaccination with Tdap vaccine among eligible 7th and 8th grade students enrolled at intervention schools compared to control schools. | The Tdap vaccination status of students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Judy Shlay, MD, MSPH | Denver Public Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Denver | Aurora | Colorado | 80045 | United States | ||
| Kaiser Permanente Colorado |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| The likelihood of vaccination with one or more HPV vaccines among eligible 7th and 8th grade female students enrolled in intervention schools compared to control schools. | The HPV vaccination status of eligible female students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. | end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| The likelihood of MCV4 vaccination among eligible 7th and 8th students enrolled in intervention schools compared to control schools. | The MCV4 vaccination status of eligible 7th and 8th grade students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. | end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| The likelihood of HPV vaccine series completion among female students in intervention schools compared to control schools. | The HPV vaccine status of female students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings. | end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011 |
| Denver |
| Colorado |
| 80231 |
| United States |